【摘要】2020 年4 月，美国肾脏基金会对肾脏病生存质量指导(kidney disease outcomes quality initiative,KDOQI)血管通路指南做了1 次重大更新，围绕终末期肾病患者生存计划开展各项治疗，内容包括终末期肾病患者的生命规划、血管通路的选择、特定并发症处理的新方法等。本文结合我国国情，对本指南进行解读，指导医生和患者共同对终末期肾病的治疗模式和血管通路做出决策，并为后续研究带来方向性的建议。
【Abstract】In April 2020, the American National Kidney Foundation made a major update to the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guideline for Vascular Access, and carried out various treatments for the survival plan of end-stage renal disease patients, including the life plan of end-stage renal disease patients, the selection of vascular access, and the new methods for handling specific complications. This article interprets this guideline according to the conditions of our country, helps doctors and patients make decisions on the treatment mode and vascular access for end-stage renal disease, and brings
directional suggestions for subsequent research.
[1]Vascular Access Work G.Clinical practice guidelines for vascular access.[J].Am J Kidney Dis, 2006, 48(1):176-247
[2]Allon M.Vascular Access for Hemodialysis Patients: New Data Should Guide Decision Making[J].Clin J Am Soc Nephrol, 2019, 14(6):954-961
[3]Lok CE, Huber TS, Lee T, et al.KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update[J].Am J Kidney Dis, 2020, 75(4):1-164
[4]Wang F, Yang C, Long J, et al.Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET)[J].Kidney Int, 2019, 95(3):501-505
[5]刘文虎, 孙雪峰, 林洪丽, 等.中国血液透析充分性临床实践指南[J].中华医学杂志, 2015, 95(34):2748-2753
[6]金其庄, 王玉柱, 叶朝阳, 施雅雪.中国血液透析用血管通路专家共识第版[J].中国血液净化, 2019, 18(06):365-381
